Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials - Wikidata - awgldk - TriplyDB

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

http://www.wikidata.org/entity/Q40842291

about

Drug Carrier for Photodynamic Cancer Therapy Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection Can nanotechnology potentiate photodynamic therapy?Fullerene-biomolecule conjugates and their biomedicinal applications.Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy Hybrid photoactive fullerene derivative-ruboxyl nanostructures for photodynamic therapy.Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH.Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria.Photoinactivation of Escherichia coli (SURE2) without intracellular uptake of the photosensitizer.Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.An investigation into the inhibitory effect of ultraviolet radiation on Trichophyton rubrum.Enterococcus--virulence and susceptibility to photodynamic therapy of clinical isolates from Lower Silesia, Poland.Antimicrobial photodynamic therapy with fulleropyrrolidine: photoinactivation mechanism of Staphylococcus aureus, in vitro and in vivo studies Photodynamic therapy with fullerenes in vivo: reality or a dream?Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals.Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: oxygen-independent photokilling in presence of azide and new mechanistic insights.Imidazoacridinone derivatives as efficient sensitizers in photoantimicrobial chemotherapy.Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies.Nanoparticles: their potential use in antibacterial photodynamic therapy.Drug discovery of antimicrobial photosensitizers using animal models.Photodynamic Therapy for Cancer and for Infections: What Is the Difference?An insight on bacterial cellular targets of photodynamic inactivation.Structure-function relationships of Nile blue (EtNBS) derivatives as antimicrobial photosensitizers.A Perspective on the Trends and Challenges Facing Porphyrin-Based Anti-Microbial Materials.Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships.Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform.Innovative strategies to overcome biofilm resistance.Advances in antimicrobial photodynamic inactivation at the nanoscale.Correlation of Carbon Dots' Light-Activated Antimicrobial Activities and Fluorescence Quantum Yield.Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.Structure-Photoproperties Relationship Investigation of the Singlet Oxygen Formation in Porphyrin-Fullerene Dyads.

P2860

Q26782780-A50F3CC5-67B1-4143-959C-3DBBAE5C36AA Q26797497-55F77421-C967-4486-8825-04341CC19C17 Q26830053-85884809-938E-430C-A3AD-E26D2B5F3FD6 Q27027057-D463551B-486C-4248-88FD-2E3F5AFE1A62 Q27027616-0C355342-EC04-4BF5-A7D4-BCDA2C369970 Q28388084-F38F15B7-98C2-4514-973A-6F0ECBEFDE78 Q28393292-3E14B5C3-8676-4CFE-A0A4-C439DACA6916 Q28829607-B5A1C825-3995-4581-A5E7-162905FE05B9 Q30634347-D2D203BB-EC93-485F-89AF-403262C664A7 Q33355620-63B016D3-431F-4981-A4D9-8B5A12D07CCE Q33875363-361366BE-DAB5-4C3D-9C25-0A3745172DBF Q34325328-89A45E1C-C316-4ED4-848F-9AFBD1C51D6E Q34414725-BD66EE4A-33F0-4468-808D-0A1EFFCA09EF Q34563021-F983154B-6F2B-4699-8D68-F8C946B88F52 Q34633649-C343F6A4-58DB-472C-9FAD-2E442743E952 Q35309068-BFC023C5-9374-41CA-8CE0-B6AB2891443F Q35597701-25BAA303-DB44-433A-BD72-C052A2AB9603 Q36206957-2FA33638-F0A2-4A77-B566-8EFF40C9DF12 Q36467138-3ACE8BA2-265E-43BA-913B-E220453A2A7C Q36487094-54F724CE-EF13-48B2-A8E7-6B66D599DFAF Q36911186-B764FF5E-60DC-405C-B09D-A8C794A72CB4 Q37384892-621536A7-EAAC-4E68-B3BE-AFED63A19B14 Q37850331-3EE25218-C3FC-4B4F-A77F-486DF68F09A1 Q37866822-30C10E3C-1DDF-4657-8C01-B202ECC6ADEF Q38068168-67EEBDB7-6965-4E43-9559-1FD38BAFB615 Q38182135-0DBBAB27-6526-4379-B90E-CF8411E9CB2D Q38565396-D5344FD2-FF7A-4AA0-AB60-A9CAE8FCF811 Q38858993-6FAB3048-8E3E-426C-8470-2F75C11B76C7 Q41835645-0E6A408D-166E-4BEC-9108-8A5C5378C704 Q42129565-D7EE0B25-1970-404B-839E-3DB7A643FB0A Q43233956-B52732B6-9E7F-4F38-9944-B47F7F1A6F78 Q46244158-1AED7563-EB41-4514-8873-3F420DC9CA06 Q46253930-2AD6415E-F1B6-43FB-ACF0-AC5D9365C72D Q46540028-187081B4-7E72-4DB0-AC0B-F1F7BDA50639 Q48058619-A2563135-C774-4F95-B98F-DE8A455D2429

P2860

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

http://www.wikidata.org/entity/Q40842291

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

@en

type

label

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

@en

prefLabel

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

@en

P1433

Q40842291-F004029B-B897-4856-8998-497AC085EF2F

P1476

Q40842291-C864B45A-5499-4935-A19A-42AFD38C3B0A

P2093

Q40842291-4D309F27-5BB7-4029-823D-88E92CEE02E5

Q40842291-4F7C9F13-A505-46D7-B3E2-40E984D82207

Q40842291-82A0B2FC-FA47-4A64-8B8D-BEE8C92CEB6E

Q40842291-86AA4F33-2A90-4F53-8175-2D4F3AE18784

Q40842291-C02F51F6-E105-4C3B-B1DB-038DED77D959

Q40842291-E83C6571-810B-4864-8FEA-8B15FD9DE0F3

Q40842291-EA5046FE-0D79-4379-A71D-2B2F842DB77A

Q40842291-F70AA772-1620-4CC9-8C44-90FB793C6FCF

P2860

Q40842291-0387598A-C052-456C-8B07-1B91EAC617FE

Q40842291-040AF097-F70A-40A7-94D6-8C999D1EB4D3

Q40842291-0B8DF4E6-0B6F-482F-ACCA-15E17574508F

Q40842291-0E54D03A-547D-4B1B-ABDD-0590628F75C1

Q40842291-1740D80B-7C5C-47AA-BFED-55546103BA59

Q40842291-2162C89D-D23A-428A-8116-3F525767DF16

Q40842291-24C208BF-B062-4E5D-878C-4A1E3E6C4788

Q40842291-27A4FB75-B369-4F44-956B-20BEF7F5E112

Q40842291-2BAFC066-537A-4067-BC7B-0CA3CCBCE41F

Q40842291-2C38E50E-3215-416F-BF69-F6E425BCB34D

P304

Q40842291-A26F7BA7-D74B-4BD3-B62C-54F193791D94

P31

Q40842291-77EF5CC4-6099-49C2-BF28-1F8A53FDED73

P356

Q40842291-ACDAAFB9-52A8-4A91-B284-3B02F82CBB48

P433

Q40842291-A114B213-3986-475E-82BE-78AE4686DD9C

P478

Q40842291-1986C4CC-A8D8-49FE-87DB-A08C4C50499F

P50

Q40842291-27C941EC-AAFE-4956-873D-F4CB4D48F090

P577

Q40842291-B00CED1D-640D-42D9-B86B-81BF857AD713

P5875

Q40842291-D47138B2-0CCA-455B-934E-E573C7368350

P698

Q40842291-3DA6A88E-E330-403B-879E-5DF29803168F

P921

Q40842291-F561DB26-5DB9-4ACE-A263-2BE78AF662E1

P932

Q40842291-87BE3D1E-C62C-4B36-9773-3DB76708CE81

P356

J.NANO.2009.10.005

P1433

Nanomedicine: Nanotechnology, Biology and Medicine

P1476

Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials

@en

P2093

Ashlee Jahnke

http://www.w3.org/2001/XMLSchema#string

George P Tegos

http://www.w3.org/2001/XMLSchema#string

Liyi Huang

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Terakawa

http://www.w3.org/2001/XMLSchema#string

Tim Wharton

http://www.w3.org/2001/XMLSchema#string

Timur Zhiyentayev

http://www.w3.org/2001/XMLSchema#string

Ying-Ying Huang

http://www.w3.org/2001/XMLSchema#string

Yohei Sawayama

http://www.w3.org/2001/XMLSchema#string

P2860

Photodynamic therapy for neovascular age-related macular degeneration

A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens

Cationic fullerenes are effective and selective antimicrobial photosensitizers

Photodynamic therapy: a new antimicrobial approach to infectious disease?

Getting started with yeast

Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues.

Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p.

Anti-microbial photodynamic therapy: useful in the future?

Study of germ tube formation by Candida albicans after photodynamic antimicrobial chemotherapy (PACT).

Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness.

P304

442-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NANO.2009.10.005

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Michael R. Hamblin

P577

2009-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38090375

http://www.w3.org/2001/XMLSchema#string

P698

19914400

http://www.w3.org/2001/XMLSchema#string

P921

P932

2879475

http://www.w3.org/2001/XMLSchema#string